220 related articles for article (PubMed ID: 25595874)
1. [IgG4-related disease treatment in 2014: Update and literature review].
Grados A; Ebbo M; Jean E; Bernit E; Harlé JR; Schleinitz N
Rev Med Interne; 2015 Jun; 36(6):395-404. PubMed ID: 25595874
[TBL] [Abstract][Full Text] [Related]
2. Bilateral Orbital IgG4-Related Disease with Systemic and Corneal Involvement Showing an Excellent Response to Steroid and Rituximab Therapy: Report of a Case with 11 Years Follow-Up.
Berta AI; Agaimy A; Braun JM; Manger B; Kruse FE; Holbach L
Orbit; 2015; 34(5):299-301. PubMed ID: 26362833
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune Pancreatitis: An Update on Diagnosis and Management.
Madhani K; Farrell JJ
Gastroenterol Clin North Am; 2016 Mar; 45(1):29-43. PubMed ID: 26895679
[TBL] [Abstract][Full Text] [Related]
4. IgG4-related disease: A relatively new concept for clinicians.
Vasaitis L
Eur J Intern Med; 2016 Jan; 27():1-9. PubMed ID: 26481243
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in autoimmune pancreatitis: type 1 and type 2.
Kamisawa T; Chari ST; Lerch MM; Kim MH; Gress TM; Shimosegawa T
Gut; 2013 Sep; 62(9):1373-80. PubMed ID: 23749606
[TBL] [Abstract][Full Text] [Related]
6. IgG4 antibodies in autoimmune polyglandular disease and IgG4-related endocrinopathies: pathophysiology and clinical characteristics.
Nambam B; Winter WE; Schatz DA
Curr Opin Pediatr; 2014 Aug; 26(4):493-9. PubMed ID: 24905103
[TBL] [Abstract][Full Text] [Related]
7. [IgG4-RELATED DISEASE].
Pokroy-Shapira E; Molad Y
Harefuah; 2017 Jul; 156(7):441-445. PubMed ID: 28786269
[TBL] [Abstract][Full Text] [Related]
8. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity.
Cheuk W; Chan JK
Adv Anat Pathol; 2010 Sep; 17(5):303-32. PubMed ID: 20733352
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis.
Wallwork R; Wallace Z; Perugino C; Sharma A; Stone JH
Medicine (Baltimore); 2018 Oct; 97(42):e12631. PubMed ID: 30334947
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease.
Zen Y; Kasashima S; Inoue D
Semin Diagn Pathol; 2012 Nov; 29(4):212-8. PubMed ID: 23068300
[TBL] [Abstract][Full Text] [Related]
11. An overview of the diagnosis and management of immunoglobulin G4-related disease.
Haldar D; Cockwell P; Richter AG; Roberts KJ; Hirschfield GM
CMAJ; 2016 Sep; 188(13):953-961. PubMed ID: 27325130
[No Abstract] [Full Text] [Related]
12. Clinical review of pulmonary manifestations of IgG4-related disease.
Campbell SN; Rubio E; Loschner AL
Ann Am Thorac Soc; 2014 Nov; 11(9):1466-75. PubMed ID: 25422997
[TBL] [Abstract][Full Text] [Related]
13. Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease: A case report.
Pomponio G; Olivari D; Mattioli M; Angeletti A; Rossetti G; Goteri G; Gabrielli A
Medicine (Baltimore); 2018 Jun; 97(26):e11143. PubMed ID: 29952960
[TBL] [Abstract][Full Text] [Related]
14. Treatment approaches to IgG4-related systemic disease.
Khosroshahi A; Stone JH
Curr Opin Rheumatol; 2011 Jan; 23(1):67-71. PubMed ID: 21124087
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Autoimmune Pancreatitis.
Hart PA; Zen Y; Chari ST
Gastroenterology; 2015 Jul; 149(1):39-51. PubMed ID: 25770706
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of rituximab in autoimmune blistering diseases.
Ahmed AR; Shetty S
Am J Clin Dermatol; 2015 Jun; 16(3):167-77. PubMed ID: 25791770
[TBL] [Abstract][Full Text] [Related]
17. Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: results from the SMART database.
Yamamoto M; Yajima H; Takahashi H; Yokoyama Y; Ishigami K; Shimizu Y; Tabeya T; Suzuki C; Naishiro Y; Takano K; Yamashita K; Hashimoto M; Keira Y; Honda S; Abe T; Suzuki Y; Mukai M; Himi T; Hasegawa T; Imai K; Shinomura Y
Mod Rheumatol; 2015 Mar; 25(2):199-204. PubMed ID: 25159154
[TBL] [Abstract][Full Text] [Related]
18. [Not Available].
Le Joncour A; Saadoun D; Cacoub P
Rev Med Interne; 2020 Dec; 41(12):822-828. PubMed ID: 32727694
[TBL] [Abstract][Full Text] [Related]
19. The treatment outcomes in IgG4-related disease.
Karim AF; Bansie RD; Rombach SM; Paridaens D; Verdijk RM; van Hagen PM; Van Laar JAM
Neth J Med; 2018 Aug; 76(6):275-285. PubMed ID: 30152392
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
